Pandemics such as Covid-19 have impacted many areas of clinical medicine, including assisted reproduction. In this presentation, Carin Huyser, PhD, and embryologist with extensive experience working with blood-borne virus seropositive IVF patients, discusses key aspects of risk minimization and preventative actions in an ART laboratory when managing samples from seropositive patients
Contributors

Carin Huyser PhD
Senior Clinical Embryologist, University of Pretoria